A One Health Study of Monkeypox Human Infection
NCT05058898 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 280
Last updated 2023-12-20
Summary
This multidisciplinary project aim to understand the epidemiology of the monkeypox in Central African Republic through the identification of the animal reservoir, the clinical and epidemiological description of the human outbreak, through an ethnological approach around risk factors of the disease and through an ecological approach of the ecological context of emergence, and the improvement of biological diagnosis.
Conditions
- Monkeypox Virus Infection
Interventions
- OTHER
-
blood samples
5 mL
- OTHER
-
Scabs and pus samples
if available
Sponsors & Collaborators
-
Institut Pasteur de Bangui
collaborator AMBIG -
Institut Pasteur
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-09
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Central African Republic
Study Locations
More Related Trials
-
Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM
NCT05629299 ·Status: UNKNOWN ·Phase: NA
-
Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
NCT05784038 ·Status: RECRUITING
-
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
NCT05651581 ·Status: COMPLETED ·Phase: NA
-
Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts
NCT07267390 ·Status: COMPLETED
-
Human Epidemiology of Newly Identified Arboviruses
NCT04954352 ·Status: UNKNOWN
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
Pan-Malaria Transmission-Blocking Vaccine AnAPN1
NCT05905432 ·Status: COMPLETED ·Phase: PHASE1
-
Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali
NCT04710316 ·Status: COMPLETED ·Phase: NA
-
Level of Immunity, Neutralization of the COVID-19 Virus and Reinfections in Residents of 2 Migrant Workers' Residences
NCT04932837 ·Status: WITHDRAWN
-
Break-through Infection Following Mpox vaccinatIon
NCT05522296 ·Status: COMPLETED
-
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
NCT03503058 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort of Patients Infected by an Arbovirus
NCT01099852 ·Status: UNKNOWN
-
Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease
NCT06692985 ·Status: COMPLETED
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC
NCT05734508 ·Status: COMPLETED ·Phase: PHASE4
-
Sero-epidemiology of Priority Arboviruses in French Guiana
NCT03210363 ·Status: COMPLETED ·Phase: NA
-
French West Indies Leptospirosis Study
NCT01607047 ·Status: UNKNOWN
-
COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey
NCT04470648 ·Status: COMPLETED
-
Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox
NCT05476744 ·Status: COMPLETED
-
Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
NCT02859350 ·Status: COMPLETED ·Phase: PHASE1
-
Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean
NCT07119086 ·Status: RECRUITING ·Phase: NA
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN
-
Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
NCT05332093 ·Status: COMPLETED
-
Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults
NCT01988636 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali
NCT03989102 ·Status: COMPLETED ·Phase: PHASE2